🔎 Trials Near Me

Home › Biliary Tract Cancer › District of Columbia › Washington

Biliary Tract Cancer clinical trials in Washington, DC

7 studies for Biliary Tract Cancer are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

RecruitingObservational study
  • National Institutes of Health Clinical Center, Bethesda · 7 mi away
Ages 2 to 100 · All sexes · Updated Oct 2, 2026 · NCT01950572

A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)

RecruitingPhase 3
  • Research Site, Washington D.C.
  • Research Site, Washington D.C.
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT07221253

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

RecruitingPhase 1/2
  • Sibley Memorial Hospital ( Site 0310), Washington D.C.
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06428409

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

RecruitingPhase 1/2
  • Avenzo Therapeutics Recruiting Site, Washington D.C.
Ages 18 to 75 · All sexes · Updated Sep 4, 2026 · NCT07038343

Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

RecruitingPhase 3
  • Research Site, Washington D.C.
Ages 18 to 99 · All sexes · Updated Aug 19, 2026 · NCT06467357

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

RecruitingPhase 1/2
  • National Institutes of Health, Bethesda · 7 mi away
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT05592626

A Study of CDX-1140, a CD40 Agonist, in Combination With Capecitabine and Oxaliplatin (CAPOX) and Keytruda in Subjects With Biliary Tract Carcinoma (BTC)

RecruitingPhase 1/2
  • National Institutes of Health Clinical Center, Bethesda · 7 mi away
Ages 18 to 120 · All sexes · Updated Mar 24, 2026 · NCT05849480

Biliary Tract Cancer trials in other cities

Other studies in Washington

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.